Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2022. "We are living in a dynamic time with a...
DaVita Inc. (NYSE: DVA), announced today it will hold a special conference call with investors on Thursday, June 23, 2022, at 8:45 a.m. Eastern Time. ...
Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the intent to form a new, independent kidney care-focused medical device...
DaVita today announced that 56 of its nephrology nurses were honored with the DAISY Award® for Extraordinary Nurses during National Nurses Week. The...
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the...
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2022. For the quarter, diluted earnings per share...
Today, DaVita Inc. highlighted its continued commitment to corporate citizenship with the publication of its annual Community Care Environmental...
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022,...
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 10,...
DaVita Inc. today announced its acquisition of transplant software company MedSleuth. Working with transplant centers across the U.S., MedSleuth aims ...
DaVita today celebrated its teammates (employees) for their contributions that helped improve the lives of kidney patients, advance innovation in...
DaVita Inc. became the first kidney care provider to completely power its North American operations with renewable energy. DaVita achieved this goal, ...
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2021. "The third quarter was another strong...
DaVita furthers commitment to climate action goals with validation from the Science Based Targets initiative (SBTi). The organization has approved...
DaVita Inc. announced today that its Board of Directors appointed a new independent director, Gregory Moore, M.D., Ph.D., to join the Board,...
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2021. For the quarter, diluted earnings per share...
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 3,...
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2021. For the quarter, diluted earnings per share...
DaVita Inc. today announced its 2025 Environmental, Social and Governance (ESG) goals and released its new ESG reports, bolstering its commitment to...
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, April 29,...
DaVita today published its inaugural Diversity & Belonging (D&B) report, which discloses its diversity metrics and roadmap for delivering its vision...
Today, the Biden administration announced a new partnership with dialysis providers to provide COVID-19 vaccinations to people receiving dialysis and ...
DaVita Inc. (NYSE: DVA) announced today that the company will participate in the 2021 Barclays Global Healthcare Conference. Joel Ackerman, DaVita's...
DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private add-on offering of $750 million...
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2020. For the full year diluted...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.